Search Results - "Ishii, Yoshimi"

Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study by Ando, Taiki, Fujisawa, Shin, Teshigawara, Haruka, Matsumura, Ayako, Sakuma, Takayuki, Suzuki, Taisei, Teranaka, Hiroshi, Ogusa, Eriko, Ishii, Yoshimi, Miyashita, Kazuho, Takahashi, Hiroyuki, Nakajima, Yuki, Miyazaki, Takuya, Hagihara, Maki, Matsumoto, Kenji, Yamazaki, Etsuko, Nakajima, Hideaki

“…We analyzed clinical cutoffs for defining computed tomography (CT) methods for sarcopenia and examined the prognostic value of CT for allogeneic hematopoietic…”
Get full text

A spurious-free, steep band rejection filter using a LiTaO3/quartz heteroacoustic layer surface acoustic wave resonator by Kadota, Michio, Ishii, Yoshimi, Tanaka, Shuji

“…We have developed prototype parallel and series types of band rejection filters at 0.9 GHz using a heteroacoustic layer (HAL) surface acoustic wave (SAW)…”
Get full text

Impact of bone marrow nucleated cell subfractions on transplant outcomes in patients with acute lymphoblastic leukemia by Nukui, Jun, Tachibana, Takayoshi, Miyazaki, Takuya, Tanaka, Masatsugu, Matsumoto, Kenji, Ishii, Yoshimi, Numata, Ayumi, Nakajima, Yuki, Matsumura, Ayako, Suzuki, Taisei, Izumi, Akihiko, Hirose, Natsuki, Yamamoto, Koji, Hagihara, Maki, Fujisawa, Shin, Nakajima, Hideaki

“…Our previous study showed that a high pre-transplant nucleated cell count in the bone marrow is associated with increased non-relapse mortality (NRM) and…”
Get full text

Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia by Ando, Taiki, Fujisawa, Shin, Teshigawara, Haruka, Ogusa, Eriko, Ishii, Yoshimi, Miyashita, Kazuho, Motohashi, Kenji, Miyazaki, Takuya, Tachibana, Takayoshi, Hagihara, Maki, Matsumoto, Kenji, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Fujita, Hiroyuki, Kanamori, Heiwa, Yamazaki, Etsuko, Nakajima, Hideaki

“…We hypothesized that treatment-related weight loss is associated with worse outcomes following HSCT. Overall, 184 patients with AML who underwent induction…”
Get full text

Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient by Ishii, Yoshimi, Itabashi, Megumi, Numata, Ayumi, Yamamoto, Wataru, Motohashi, Kenji, Hagihara, Maki, Matsumoto, Kenji, Fujisawa, Shin

“…Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive T-cell lymphoma. A 63-year-old man was diagnosed with AITL. He received 6 cycles of CHOP therapy,…”
Get full text

Anemia Associated with Worse Outcome in Diffuse Large B-Cell Lymphoma Patients: A Single-Center Retrospective Study by Matsumoto, Kenji, Fujisawa, Shin, Ando, Taiki, Koyama, Megumi, Koyama, Satoshi, Ishii, Yoshimi, Numata, Ayumi, Yamamoto, Wataru, Motohashi, Kenji, Hagihara, Maki, Nakajima, Hideaki

“…Useful prognostic biomarkers for diffuse large B-cell lymphoma (DLBCL) patients have been reported. To determine the prognostic value of hemoglobin (Hb) level…”
Get full text

Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study by Matsumura, Ayako, Miyazaki, Takuya, Tachibana, Takayoshi, Ando, Taiki, Koyama, Megumi, Koyama, Satoshi, Ishii, Yoshimi, Takahashi, Hiroyuki, Nakajima, Yuki, Numata, Ayumi, Yamamoto, Wataru, Motohashi, Kenji, Hagihara, Maki, Matsumoto, Kenji, Fujisawa, Shin, Nakajima, Hideaki

“…A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM)…”
Get full text

Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study by Takahashi, Hiroyuki, Sakai, Rika, Sakuma, Takayuki, Matsumura, Ayako, Miyashita, Kazuho, Ishii, Yoshimi, Nakajima, Yuki, Numata, Ayumi, Hattori, Yukako, Miyazaki, Takuya, Hashimoto, Chizuko, Koharazawa, Hideyuki, Takemura, Sachiya, Taguchi, Jun, Fujimaki, Katsumichi, Fujita, Hiroyuki, Nakajima, Hideaki

“…We performed a retrospective analysis of DLBCL with breast involvement to compare the prognosis of primary breast lymphoma (PBL) to secondary breast lymphoma…”
Get full text

Body mass index is a prognostic factor in adult patients with acute myeloid leukemia by Ando, Taiki, Yamazaki, Etsuko, Ogusa, Eriko, Ishii, Yoshimi, Yamamoto, Wataru, Motohashi, Kenji, Tachibana, Takayoshi, Hagihara, Maki, Matsumoto, Kenji, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Fujita, Hiroyuki, Kanamori, Heiwa, Fujisawa, Shin, Nakajima, Hideaki

“…Body mass index (BMI), which represents the proportion of weight to height, is a controversial prognostic factor for acute myeloid leukemia (AML). We evaluated…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis by Yamamoto, Wataru, Andou, Taiki, Itabashi, Megumi, Koyama, Satoshi, Ishii, Yoshimi, Numata, Ayumi, Motohashi, Kenji, Hagihara, Maki, Matsumoto, Kenji, Fujisawa, Shin

“…Objective Fludarabine plus melphalan (FM) and fludarabine plus busulfan (FB) are two major conditioning regimens for allogeneic hematopoietic stem cell…”
Get full text

Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study by Yamamoto, Wataru, Nakamura, Naoya, Tomita, Naoto, Takeuchi, Kengo, Ishii, Yoshimi, Takahashi, Hiroyuki, Watanabe, Reina, Takasaki, Hirotaka, Motomura, Shigeki, Kobayashi, Shoichi, Yokose, Tomoyuki, Ishigatsubo, Yoshiaki, Sakai, Rika

“…Abstract Loss of human leukocyte antigen (HLA)-DR expression may be related to a poor prognosis of diffuse large B-cell lymphoma (DLBCL), and tumor-associated…”
Get full text

Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study by Ishii, Yoshimi, Fujisawa, Shin, Ando, Taiki, Suzuki, Taisei, Ishiyama, Yasufumi, Kishimoto, Kumiko, Hattori, Yukako, Nakajima, Yuki, Miyazaki, Takuya, Takasaki, Hirotaka, Matsumoto, Kenji, Koharazawa, Hideyuki, Taguchi, Jun, Fujimaki, Katsumichi, Sakai, Rika, Nakajima, Hideaki

“…Aim Primary malignant lymphomas arising from the female genital tract are very rare, with an incidence rate of 0.5%. Because of its rarity, its clinical…”
Get full text

A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder by Matsumoto, Ruby, Numata, Kazushi, Doba, Nobutaka, Hara, Koji, Chuma, Makoto, Fukuda, Hiroyuki, Nozaki, Akito, Tanaka, Katsuaki, Ishii, Yoshimi, Maeda, Shin

“…Patients receiving methotrexate (MTX) for the treatment of autoimmune disease are at a high risk of developing lymphoproliferative disorders (LPD), the…”
Get full text

Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma by Tomita, Naoto, Takasaki, Hirotaka, Fujisawa, Shin, Miyashita, Kazuho, Ogusa, Eriko, Kishimoto, Kumiko, Matsuura, Shiro, Sakai, Rika, Koharazawa, Hideyuki, Yamamoto, Wataru, Fujimaki, Katsumichi, Fujita, Hiroyuki, Ishii, Yoshimi, Taguchi, Jun, Kuwabara, Hideyuki, Motomura, Shigeki, Ishigatsubo, Yoshiaki

“…The introduction of rituximab (R) has measurably improved the outcome of patients with follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). To…”
Get full text

Clinical features of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue by Ishii, Yoshimi, Tomita, Naoto, Takasaki, Hirotaka, Ogusa, Eriko, Hattori, Yukako, Matsuura, Shiro, Matsumoto, Chihiro, Takemura, Sachiya, Kuwabara, Hideyuki, Ishigatsubo, Yoshiaki

“…We newly diagnosed 131 patients with extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue lymphoma between 1998 and 2010. We retrospectively…”
Get full text

Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation by Ishii, Yoshimi, Yamazaki, Etsuko, Ishiyama, Yasufumi, Yamamoto, Eri, Hattori, Yukako, Hagihara, Maki, Tomita, Naoto, Ishigatsubo, Yoshiaki

“…POEMS syndrome is a monoclonal plasma cell disorder characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes…”
Get full text

Effects of granule-bound starch synthase I-defective mutation on the morphology and structure of pyrenoidal starch in Chlamydomonas by Izumo, Asako, Fujiwara, Shoko, Sakurai, Toshihiro, Ball, Steven G., Ishii, Yoshimi, Ono, Hikaru, Yoshida, Mayumi, Fujita, Naoko, Nakamura, Yasunori, Buléon, Alain, Tsuzuki, Mikio

“…▶ GBSS affects morphology of pyrenoidal starch. ▶ Normal GBSS activity is required to obtain the high A-type crystallinity levels. ▶ GBSS-induced starch…”
Get full text

Surface Acoustic Wave Resonators With Hetero Acoustic Layer (HAL) Structure Using Lithium Tantalate and Quartz by Kadota, Michio, Ishii, Yoshimi, Tanaka, Shuji

“…This article reports a new concept of surface-acoustic-wave (SAW) resonator, which uses shear horizontal (SH) wave confined in a thin LiTaO 3 (LT) layer…”
Get full text

Upfront Autologous Stem Cell Transplantation for Untreated High-Risk Diffuse Large B-Cell Lymphoma in Patients Up to 60 Years of Age by Takasaki, Hirotaka, Hashimoto, Chizuko, Fujita, Atsuko, Matsumoto, Kenji, Taguchi, Jun, Kuwabara, Hideyuki, Yamazaki, Etsuko, Koharazawa, Hideyuki, Fujita, Hiroyuki, Fujisawa, Shin, Ishii, Yoshimi, Yamamoto, Wataru, Motomura, Shigeki, Tomita, Naoto, Ishigatsubo, Yoshiaki, Sakai, Rika

“…Micro-Abstract We retrospectively investigated high-dose chemotherapy (HDT) plus rituximab followed by autologous stem cell transplantation (ASCT) for patients…”
Get full text

Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia by Morishita, Sakura, Hagihara, Maki, Itabashi, Megumi, Ishii, Yoshimi, Yamamoto, Wataru, Numata, Ayumi, Motohashi, Kenji, Matsumoto, Kenji, Fujisawa, Shin, Nakajima, Hideaki

“…We present a 36-year-old woman who had been taking oral dasatinib for 3 years for the treatment of chronic myelogenous leukemia (CML). Although adverse events…”
Get more information